Literature DB >> 21348821

The evil axis of obesity, inflammation and type-2 diabetes.

Arghya Das1, Sangita Mukhopadhyay.   

Abstract

Obesity and type 2 diabetes (T2D) are global problems affecting all age groups and have been characterized as lifestyle disorders. Though no study has clearly proved a direct correlation between obesity and T2D, a number of factors are associated with obesity causing insulin resistance and T2D. The factors such as adipokines and various transcription factors help to maintain a proper metabolic state in the body. Deregulation in any of these signalling balances due to obesity may trigger an inflammatory cascade which could lead to the aforesaid problems of insulin resistance and T2D. In this review, we have discussed the factors that probably link inflammation to obesity-induced insulin resistance and subsequently T2D and the possible therapeutic opportunities to decrease health risk of T2D in future.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21348821     DOI: 10.2174/187153011794982086

Source DB:  PubMed          Journal:  Endocr Metab Immune Disord Drug Targets        ISSN: 1871-5303            Impact factor:   2.895


  23 in total

Review 1.  Interaction between cytokines and inflammatory cells in islet dysfunction, insulin resistance and vascular disease.

Authors:  Y Imai; A D Dobrian; J R Weaver; M J Butcher; B K Cole; E V Galkina; M A Morris; D A Taylor-Fishwick; J L Nadler
Journal:  Diabetes Obes Metab       Date:  2013-09       Impact factor: 6.577

Review 2.  Targeting inflammation in diabetes: Newer therapeutic options.

Authors:  Neeraj Kumar Agrawal; Saket Kant
Journal:  World J Diabetes       Date:  2014-10-15

3.  Characterization of Eicosanoids Produced by Adipocyte Lipolysis: IMPLICATION OF CYCLOOXYGENASE-2 IN ADIPOSE INFLAMMATION.

Authors:  Allison Gartung; Jiawei Zhao; Simon Chen; Emilio Mottillo; Garrett C VanHecke; Young-Hoon Ahn; Krishna Rao Maddipati; Andrey Sorokin; James Granneman; Menq-Jer Lee
Journal:  J Biol Chem       Date:  2016-05-31       Impact factor: 5.157

4.  Anti-inflammatory Action of Metformin with Respect to CX3CL1/CX3CR1 Signaling in Human Placental Circulation in Normal-Glucose Versus High-Glucose Environments.

Authors:  D Szukiewicz; Grzegorz Szewczyk; Michal Pyzlak; Aleksandra Stangret; Michal Bachanek; Seweryn Trojanowski; Habib Alkhalayla; Jaroslaw Wejman
Journal:  Inflammation       Date:  2018-12       Impact factor: 4.092

5.  Association of hematological indicies with diabetes, impaired glucose regulation and microvascular complications of diabetes.

Authors:  Levent Demirtas; Husnu Degirmenci; Emin Murat Akbas; Adalet Ozcicek; Aysu Timuroglu; Ali Gurel; Fatih Ozcicek
Journal:  Int J Clin Exp Med       Date:  2015-07-15

Review 6.  A role for sphingolipids in the pathophysiology of obesity-induced inflammation.

Authors:  Benjamin T Bikman
Journal:  Cell Mol Life Sci       Date:  2012-07       Impact factor: 9.261

Review 7.  Insulin and glucagon signaling in the central nervous system.

Authors:  Beatrice M Filippi; Mona A Abraham; Jessica T Y Yue; Tony K T Lam
Journal:  Rev Endocr Metab Disord       Date:  2013-12       Impact factor: 6.514

8.  Insulin resistance elicited in postpubertal primate offspring deprived of estrogen in utero.

Authors:  Gerald J Pepe; Adina Maniu; Graham Aberdeen; Terrie J Lynch; Soon Ok Kim; Jerry Nadler; Eugene D Albrecht
Journal:  Endocrine       Date:  2016-10-21       Impact factor: 3.633

9.  Modeling diabetes disease progression and salsalate intervention in Goto-Kakizaki rats.

Authors:  Yanguang Cao; Debra C Dubois; Hao Sun; Richard R Almon; William J Jusko
Journal:  J Pharmacol Exp Ther       Date:  2011-09-08       Impact factor: 4.030

Review 10.  Islet inflammation: a unifying target for diabetes treatment?

Authors:  Yumi Imai; Anca D Dobrian; Margaret A Morris; Jerry L Nadler
Journal:  Trends Endocrinol Metab       Date:  2013-02-26       Impact factor: 12.015

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.